Accolades

Rankings

Ranked in Band 1 by Chambers China Life Sciences 2019 and Chambers Asia-Pacific Life Sciences 2019, Ropes & Gray has one of Asia’s most active and experienced China life sciences legal practices. Further recognition of our efforts in both the regulatory and transactional spaces within the region include:

  • Chambers Asia Pacific 2014-2019: Asia’s Leading Lawyers for Business: Recognized in Band 1 as a top-tier “Life Sciences” practice in the Asia-Pacific region and in China, with multiple attorneys ranked as leaders in the field.
  • Chambers Global 2008-2019: The World’s Leading Lawyers for Business: Ranked internationally as a leading “Life Sciences” practice, with multiple attorneys listed as leaders.
  • Legal 500 Asia Pacific 2018-2019Recognized in Band 1 as a top-tier “Healthcare & Life Sciences” practice in China, with multiple attorneys ranked as leaders in the field.
  • China Law & Practice 2017: Named Ropes & Gray the international “Healthcare & Life Sciences Firm of the Year.”
  • Chambers USA 2007-2019: America’s Leading Lawyers for Business: Ranked as a leading national “Life Sciences” practice, with multiple attorneys listed as leaders.
  • Chambers USA 2008-2019: America’s Leading Lawyers for Business: FDA practice ranked in Washington, D.C. as a leading “Health Care: Pharmaceutical/Medical Products Regulatory” practice, with multiple attorneys listed as leaders.
  • U.S. News-Best Lawyers “Best Law Firms” 2016-2019: Ranked in the top tier nationally and by region in Massachusetts and New York for "Biotechnology Law;" ranked in the top tier by region in Washington, D.C. and nationwide for "FDA Law;" ranked in the top tier by region in Massachusetts and nationwide for “M&A Law.”
  • U.S News-Best Lawyers “Best Law Firms” 2016: Named “Firm of the Year” for Biotechnology Law.
  • Legal 500 U.S. 2013-2018: Ranked highly for “Healthcare: Life Sciences,” with multiple attorneys ranked as leaders in their field.
  • LMG Life Sciences Awards 2016-2018: Ranked highly for “Regulatory: FDA Pharmaceutical,” “Transactional: Corporate, Licensing & Collaborations, M&A, and Venture Capital” with multiple attorneys ranked as life sciences stars; ranked for “Regulatory: FDA Medical Devices” and “Government Investigations,” with multiple attorneys ranked as life sciences stars.
  • LMG Life Sciences Awards 2018: Winner of the “Finance & Transactional Impact Deal of the Year” and “Licensing & Collaboration Firm of the Year” awards.
Cookie Settings